search
Back to results

Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer

Primary Purpose

FET

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Low oestrogen dosage
Sponsored by
Nanjing University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for FET

Eligibility Criteria

20 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Female;
  2. Aged between 20 and 40 years old;
  3. Frozen thawed embryo transfer is proposed, and the type of transferred embryo is blastocyst (the number of transferred embryos is 1);
  4. Body mass index (BMI) ≤ 28 kg/m2, ≥ 18.5 kg/m2;
  5. The total number of transfer cycles was < 3;
  6. Volunteer to participate in the study and sign the informed consent.

Exclusion Criteria:

  1. Patients with chromosomal abnormalities;
  2. Contraindications to hormone replacement therapy;
  3. Patients with uterine myoma, severe adenomyosis, endometriosis, congenital uterine malformation, endometrial tuberculosis, intrauterine adhesions and other diseases that significantly affect embryo implantation;
  4. Participating in other clinical studies.

Sites / Locations

  • Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical SchoolRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Low oestrogen

Regular oestrogen

Arm Description

The patients take orally estradiol tablets 2 mg (Femoston) q.d. during the HRT-FET cycles

The patients take orally estradiol tablets 2 mg (Femoston) t.i.d. during the HRT-FET cycles

Outcomes

Primary Outcome Measures

Clinical pregnancy rate
Clinical pregnancy is defined as the presence of gestational sac observed by ultrasound. The proportion of clinical pregnancy cycles to total FET cycles is the clinical pregnancy rate.

Secondary Outcome Measures

Embryo implantation rate
The proportion of the number of implanted embryos to the total number of transferred embryos is the embryo implantation rate.
Early pregnancy loss rate
The early pregnancy loss rate refers to the proportion of patients with pregnancy loss before 12 weeks of gestation in the total clinical pregnancy patients.
Incidence of thrombosis
Thrombosis incidence refers to the proportion of patients with deep venous thrombosis in the total patients.
Incidence rate of gestational hypertension
The incidence rate of gestational hypertension refers to the proportion of patients with gestational hypertension in the total pregnant patients.
Premature birth rate
Preterm birth rate refers to the proportion of patients with preterm birth in all pregnancies.
Proportion of low birth weight infants
The proportion of low birth weight infants refers to the proportion of low birth weight infants in all newborns.

Full Information

First Posted
September 15, 2022
Last Updated
September 15, 2022
Sponsor
Nanjing University
search

1. Study Identification

Unique Protocol Identification Number
NCT05545592
Brief Title
Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer
Official Title
A Randomized Controlled Trial on Reducing Oestrogen Dosage to Improve the Clinical Outcome of Frozen-thawed Embryo Transfer
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2022 (Anticipated)
Primary Completion Date
June 1, 2025 (Anticipated)
Study Completion Date
June 1, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nanjing University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is a single-center, randomized, controlled prospective study. Those who will recieve hormone replacement therapy-frozen thawed embryo transfer (HRT-FET) are enrolled in the study. To determine the effect of oestrogen dosage reducion on maternal and fetal complications in HRT-FET cycles while maintaining the similar clinical pregnancy outcome in HRT-FET cycles with regular oestrogen dosage.
Detailed Description
According to the enrollment and exclusion criteria, the patients were enrolled, and the subjects were randomly divided into two groups by computer randomization. Group A was the reduced oestrogen dosage group (test group). Group B was the regular hormone replacement group (control group).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
FET

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
660 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low oestrogen
Arm Type
Experimental
Arm Description
The patients take orally estradiol tablets 2 mg (Femoston) q.d. during the HRT-FET cycles
Arm Title
Regular oestrogen
Arm Type
No Intervention
Arm Description
The patients take orally estradiol tablets 2 mg (Femoston) t.i.d. during the HRT-FET cycles
Intervention Type
Other
Intervention Name(s)
Low oestrogen dosage
Intervention Description
From the second day of the menstrual cycle, femoston (estradiol tablets) were orally taken 2 mg q.d.. The endometrial thickness and serum oestrogen and progesterone levels were monitored on the 12th to 14th days of the menstrual cycle.
Primary Outcome Measure Information:
Title
Clinical pregnancy rate
Description
Clinical pregnancy is defined as the presence of gestational sac observed by ultrasound. The proportion of clinical pregnancy cycles to total FET cycles is the clinical pregnancy rate.
Time Frame
45 days after embryo transfer
Secondary Outcome Measure Information:
Title
Embryo implantation rate
Description
The proportion of the number of implanted embryos to the total number of transferred embryos is the embryo implantation rate.
Time Frame
45 days after embryo transfer
Title
Early pregnancy loss rate
Description
The early pregnancy loss rate refers to the proportion of patients with pregnancy loss before 12 weeks of gestation in the total clinical pregnancy patients.
Time Frame
12 weeks after embryo transfer
Title
Incidence of thrombosis
Description
Thrombosis incidence refers to the proportion of patients with deep venous thrombosis in the total patients.
Time Frame
12 weeks after embryo transfer
Title
Incidence rate of gestational hypertension
Description
The incidence rate of gestational hypertension refers to the proportion of patients with gestational hypertension in the total pregnant patients.
Time Frame
45 weeks after embryo transfer
Title
Premature birth rate
Description
Preterm birth rate refers to the proportion of patients with preterm birth in all pregnancies.
Time Frame
41 weeks after embryo transfer
Title
Proportion of low birth weight infants
Description
The proportion of low birth weight infants refers to the proportion of low birth weight infants in all newborns.
Time Frame
41 weeks after embryo transfer

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Female; Aged between 20 and 40 years old; Frozen thawed embryo transfer is proposed, and the type of transferred embryo is blastocyst (the number of transferred embryos is 1); Body mass index (BMI) ≤ 28 kg/m2, ≥ 18.5 kg/m2; The total number of transfer cycles was < 3; Volunteer to participate in the study and sign the informed consent. Exclusion Criteria: Patients with chromosomal abnormalities; Contraindications to hormone replacement therapy; Patients with uterine myoma, severe adenomyosis, endometriosis, congenital uterine malformation, endometrial tuberculosis, intrauterine adhesions and other diseases that significantly affect embryo implantation; Participating in other clinical studies.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jun Xing
Phone
+862583107188
Email
xing.jun@msn.com
First Name & Middle Initial & Last Name or Official Title & Degree
Chenyang Huang
Phone
+862583107188
Email
dianshui19901562@126.com
Facility Information:
Facility Name
Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210008
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jun Xing
Phone
+86 25 8310 7188
Email
xing.jun@msn.com

12. IPD Sharing Statement

Learn more about this trial

Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer

We'll reach out to this number within 24 hrs